Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Stephanie Booy"'
Autor:
Amber Blaauboer, Stephanie Booy, Peter M. van Koetsveld, Bas Karels, Fadime Dogan, Suzanne van Zwienen, Casper H. J. van Eijck, Leo J. Hofland
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background Adjuvant gemcitabine for pancreatic cancer has limited efficacy in the clinical setting. Impaired drug metabolism is associated with treatment resistance. We aimed to evaluate the chemosensitising effect of interferon-beta (IFN-β
Externí odkaz:
https://doaj.org/article/d7528e192b7149b28bd793a959ebfbe7
Autor:
Bas Karels, Amber Blaauboer, Casper H.J. van Eijck, Suzanne van Zwienen, Stephanie Booy, Fadime Dogan, Peter M. van Koetsveld, Leo J. Hofland
Publikováno v:
BMC Cancer
BMC Cancer, 20(1):913. BioMed Central Ltd.
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
BMC Cancer, 20(1):913. BioMed Central Ltd.
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
Background Adjuvant gemcitabine for pancreatic cancer has limited efficacy in the clinical setting. Impaired drug metabolism is associated with treatment resistance. We aimed to evaluate the chemosensitising effect of interferon-beta (IFN-β). Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6c34c37deae3142c65fd2f1f4f2f8a1
https://doi.org/10.21203/rs.3.rs-39801/v3
https://doi.org/10.21203/rs.3.rs-39801/v3
Autor:
Casper H.J. van Eijck, Leo J. Hofland, Peter M. van Koetsveld, Bas Karels, Stephanie Booy, Suzanne vanZwienen, Fadime Dogan, Amber Blaauboer
Publikováno v:
Advances in Cancer Research & Clinical Imaging. 2
Publikováno v:
Journal of Interferon and Cytokine Research, 35(5), 327-339. Mary Ann Liebert Inc.
Pancreatic cancer is a highly aggressive malignancy with limited treatment options. To improve survival for patients with pancreatic cancer, research has focused on other treatment modalities like adding biological modulators such as type-I interfero
Publikováno v:
Journal of Cellular and Molecular Medicine
Journal of Cellular and Molecular Medicine, 18(3), 492-502. Wiley-Blackwell Publishing Ltd
Journal of Cellular and Molecular Medicine, 18(3), 492-502. Wiley-Blackwell Publishing Ltd
Pancreatic cancer is a highly aggressive malignancy with limited treatment options. Type-I interferons (e.g. IFN-α/-β) have several anti-tumour activities. Over the past few years, clinical studies evaluating the effect of adjuvant IFN-α therapy i
Autor:
Stephanie Booy, Casper Van Eijck, Janssen, Joseph A. M. J. L., Fadime Dogan, Koetsveld, Peter M., Leo Hofland
Publikováno v:
American Journal of Cancer Research, 5(6), 2035-2046. e-Century Publishing Corporation
EUR Research Portal
EUR Research Portal
Introduction: Pancreatic cancer is a highly aggressive malignancy with few treatment options. The overexpression of several growth factors, including insulin and insulin-like growth factors (IGFs), can underlie the aggressive nature of this disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6b09547de09efafbf78db4b95989cd1f
https://europepmc.org/articles/PMC4529622/
https://europepmc.org/articles/PMC4529622/
Autor:
Leo J. Hofland, Stephanie Booy, Casper H.J. van Eijck, Joop A. M. J. L. Janssen, Peter M. van Koetsveld, Fadime Dogan
Publikováno v:
Annals of Oncology. 24:iv49